Clinical Trials Logo

Type 2 Diabetes clinical trials

View clinical trials related to Type 2 Diabetes.

Filter by:

NCT ID: NCT02134860 Completed - Type 2 Diabetes Clinical Trials

Bed Rest, Alternate Daily Fasting and Incretin Effect

Start date: June 2014
Phase: N/A
Study type: Interventional

Bed rest produces insulin resistance in healthy volunteers. In this study the investigators aim to investigate the effect of 8 days bed rest on the incretin effect and how alternate daily fasting affects cognitive function and the insulin resistance produced by bed rest. The subjects will be randomized to either 3 meals a day (isocaloric diet), alternate daily fasting or one meal/day every second day (25% of daily calorie need) and four meals/day every second (175% of daily calorie need). The investigators hypothesize: 1. Bed rest reduces the incretin effect 2. Alternate daily fasting improves the cognitive function (memory and concentration) compared to isocaloric diet 3. Alternate daily fasting reduces insulin resistance produced by bed rest compared to isocaloric diet

NCT ID: NCT02132442 Completed - Type 2 Diabetes Clinical Trials

Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes

VDLS
Start date: March 2014
Phase: Phase 3
Study type: Interventional

This study is designed to study the effect of vitamin D intake on the severity of fatty liver and poor glucose control in patients with type 2 diabetes and fatty liver disease.

NCT ID: NCT02130401 Completed - Type 2 Diabetes Clinical Trials

Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes

Start date: June 2014
Phase: N/A
Study type: Interventional

This is a pilot study with a single active treatment arm. The study is designed to assess the efficacy of a portable, non-invasive neuromodulation system for the treatment of Type 2 Diabetes. In particular, the primary outcome measure is a reduction in A1c.

NCT ID: NCT02129985 Recruiting - Type 2 Diabetes Clinical Trials

Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy

T2DMRS
Start date: February 2014
Phase: Phase 4
Study type: Interventional

Whether GLP-1 receptor agonists sequential therapy in newly diagnosed type 2 diabetic patients can further improve glycemic control, diabetes remission rate and β-cell function after the short-term insulin intensive therapy.

NCT ID: NCT02128815 Completed - Type 2 Diabetes Clinical Trials

Evaluating the Effect of a Diabetes Health Coach in Individuals With Type 2 Diabetes

DiabCoach
Start date: January 2015
Phase: N/A
Study type: Interventional

Background: Health coaching is defined as health education, promotion and support by a professional to enhance the well-being of individuals and facilitate the achievement of their health-related goals. However, health coaching has not been adequately assessed in the community health care setting in individuals with T2DM. The purpose of this study is to determine the effect of diabetes health coaching in adults with T2DM in the community health care setting on clinical outcomes, self-care behaviours and health care utilization.

NCT ID: NCT02126358 Completed - Type 2 Diabetes Clinical Trials

Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)

Start date: May 2014
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and safety of the fix-dose combination therapy with Gemigliptin 50mg and Rosuvastatin 20mg with type 2 diabetes and dyslipidemia

NCT ID: NCT02123901 Completed - Type 2 Diabetes Clinical Trials

The Effect of Walking Meditation Training on Glycemic Control and Vascular Function in Patients With Type 2 Diabetes

Start date: December 2013
Phase: N/A
Study type: Interventional

Walking Meditation training would yield more favorable adaptations than walking alone in improving glycemic control and vascular function in patients with type 2 diabetes.

NCT ID: NCT02122835 Withdrawn - Heart Failure Clinical Trials

Exercise, Heart Failure, and Type 2 Diabetes

Start date: February 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to understand the differences in how patients with heart failure respond to exercise training compared to patients with heart failure and type 2 diabetes.

NCT ID: NCT02122250 Completed - Type 2 Diabetes Clinical Trials

Web-based Support for People With Type 2 Diabetes

Start date: October 2014
Phase: N/A
Study type: Interventional

This project will address vital questions regarding how best to design web-based materials for the growing population of patients with basic literacy and computer skills but lower levels of health literacy, building on our previous experience of developing web-based materials for people with lower levels of literacy and health literacy. This study will be carried out two phases. Phase 1 will use qualitative methods to understand user experiences of the web-based materials through observational 'think-aloud' interviews with users. Phase 2 will test the newly developed web-based materials to a static (non-interactive) version of the materials online.

NCT ID: NCT02121717 Completed - Type 2 Diabetes Clinical Trials

Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients

CMAP
Start date: June 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Chiglitazar, compare with placebo.